Antibody clues could predict kidney transplant outcomes
NCT ID NCT07374484
First seen Jan 30, 2026 · Last updated Jun 21, 2026 · Updated 20 times
Summary
This study looked at how levels of a specific antibody (AT1R-Ab) change before and after kidney transplantation in 241 patients. Researchers monitored these antibodies over one year to see if they relate to kidney function and graft survival. The goal is to find better ways to predict transplant success and improve decision-making for doctors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors better predict kidney transplant success and personalize care for recipients.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all transplant patients.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.